A Study to Assess the Effect of Race on How a Single Dose of ASP3652 is Taken up, Metabolized and Distributed Through the Bodies of Young, Healthy Male and Female Subjects, and Its Safety and Tolerability

NCT01958047 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics
Pharmacodynamics
Healthy Subjects
Effect of Race

Interventions

DRUG: ASP3652

Sponsor

Astellas Pharma Europe B.V.